Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less.
Arch Pathol Lab Med. 2018.
PMID: 29494220
Review.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1999 | 1 |
| 2001 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2025 | 0 |
Search Results
32 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less.
Arch Pathol Lab Med. 2018 Mar;142(3):291-298. doi: 10.5858/arpa.2017-0208-RA.
Arch Pathol Lab Med. 2018.
PMID: 29494220
Free article.
Review.
CONTEXT: - The rapid advances in targeted therapies in non-small cell lung cancer (NSCLC) make the optimization and implementation of cytology specimens for molecular testing a priority. ...OBJECTIVE: - To report the many advances in molecular cytopath …
CONTEXT: - The rapid advances in targeted therapies in non-small cell lung cancer (NSCLC) make the optimization and implementation of …
Cytologic diagnosis of round cell sarcomas in the era of ancillary testing: an updated review.
J Am Soc Cytopathol. 2018 May-Jun;7(3):119-132. doi: 10.1016/j.jasc.2017.12.002. Epub 2017 Dec 15.
J Am Soc Cytopathol. 2018.
PMID: 31043308
Review.
Round cell sarcomas constitute a large proportion of "small round blue cell tumors," which encompass a broad differential diagnosis and can be difficult to distinguish on cytomorphologic grounds alone. Numerous pathogenetic insights and advances in ancillary testing …
Round cell sarcomas constitute a large proportion of "small round blue cell tumors," which encompass a broad differential diag …
Myxoid liposarcoma: Fine-needle aspiration cytopathology in the molecular era. A report of 24 cases.
J Am Soc Cytopathol. 2016 May-Jun;5(3):162-169. doi: 10.1016/j.jasc.2015.09.211. Epub 2015 Sep 15.
J Am Soc Cytopathol. 2016.
PMID: 31042519
We report our FNA experience with myxoid LPS and application of this molecular probe. MATERIALS AND METHODS: Specimens retrieved from our cytology database used search codes for myxoid LPS. ...FISH analysis for DDIT3 rearrangement from unstained smears and/or …
We report our FNA experience with myxoid LPS and application of this molecular probe. MATERIALS AND METHODS: Specimens retrieved from …
Role of FNAC, fluid specimens, and cell blocks for cytological diagnosis of lung cancer in the present era.
J Cytol. 2015 Oct-Dec;32(4):217-22. doi: 10.4103/0970-9371.171219.
J Cytol. 2015.
PMID: 26811567
Free PMC article.
Review.
Cytoblocks prepared from residual tissue fluids and fine-needle aspirations can be useful adjuncts to smears for establishing a more definitive cytopathologic diagnosis. These paraffin embedded cytoblocks have been popular since these can be handled like any other histolog …
Cytoblocks prepared from residual tissue fluids and fine-needle aspirations can be useful adjuncts to smears for establishing a more …
Myeloid Sarcoma: Features in Cytological Preparations and the Utility of Rapid On-Site Evaluation (ROSE) in Triage.
Acta Cytol. 2023;67(1):55-69. doi: 10.1159/000526635. Epub 2022 Nov 1.
Acta Cytol. 2023.
PMID: 36318898
METHODS: A retrospective review was performed for cases of MS with concurrent cytology and ROSE results from 2006 to 2017. FNA smears and touch preparations were reviewed, and the results of ROSE, immunohistochemistry (IHC), flow cytometric immunophenotyping (FCI), …
METHODS: A retrospective review was performed for cases of MS with concurrent cytology and ROSE results from 2006 to 2017. FNA sme …
Changing Trends and Practices in Cytopathology.
Acta Cytol. 2017;61(2):91-95. doi: 10.1159/000460236. Epub 2017 Mar 22.
Acta Cytol. 2017.
PMID: 28324872
Review.
The "need to do more with less" in the era of targeted therapy/personalized medicine has resulted in an increasing preference for needle core biopsy when performing a rapid on-site evaluation. ...It is pertinent that cytopathologists as a group recognize this change and pr …
The "need to do more with less" in the era of targeted therapy/personalized medicine has resulted in an increasing preference for nee …
Value of additional sections: Tissue handling of small biopsies in detecting squamous dysplasia of the uterine cervix.
Ann Diagn Pathol. 2022 Feb;56:151872. doi: 10.1016/j.anndiagpath.2021.151872. Epub 2021 Dec 8.
Ann Diagn Pathol. 2022.
PMID: 34896888
Cervical cancer screening is currently based on high-risk human papillomavirus (HR-HPV) molecular testing, Pap cytology testing, and histologic evaluation of cervical biopsies. ...An initial impression of atypia significantly correlated with both a change in diagnos …
Cervical cancer screening is currently based on high-risk human papillomavirus (HR-HPV) molecular testing, Pap cytology testin …
Molecular diagnostics of melanoma fine-needle aspirates: a cytology-histology correlation study.
Am J Clin Pathol. 2012 Nov;138(5):670-7. doi: 10.1309/AJCPEQJW3PLOOZTC.
Am J Clin Pathol. 2012.
PMID: 23086767
DNA was purified from Diff-Quik-stained FNA smears and tissue blocks from corresponding excisions in parallel. BRAF mutation status was successfully obtained from both specimen types in 34 (92%) of 37 cases. ...Results of BRAF mutational analysis were concordant in all 34 …
DNA was purified from Diff-Quik-stained FNA smears and tissue blocks from corresponding excisions in parallel. BRAF mutation status w …
A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA.
Sociol Health Illn. 2012 Feb;34(2):234-50. doi: 10.1111/j.1467-9566.2011.01411.x. Epub 2011 Nov 25.
Sociol Health Illn. 2012.
PMID: 22118240
Free article.
Review.
DNA-based molecular testing for human papillomavirus has emerged as a novel approach to cervical cancer screening in the context of well-entrenched existing technology, the Pap smear. ...We illustrate how, although Pap has long been problematised and could be seen a …
DNA-based molecular testing for human papillomavirus has emerged as a novel approach to cervical cancer screening in the context of w …
Evaluating the Performance of Hybrid Capture 2 Test as a Primary Screening Test from Studies Conducted in Low and Middle-Income Country Settings- Special Focus India.
Asian Pac J Cancer Prev. 2021 Aug 1;22(8):2709-2716. doi: 10.31557/APJCP.2021.22.8.2709.
Asian Pac J Cancer Prev. 2021.
PMID: 34452578
Free PMC article.
Among the screening tests for cervical cancer, advantages of screening with second generation molecular Hybrid Capture 2 (HC2) test is the high sensitivity and negative predictive value that makes it easy to implement as a cervical cancer screening policy necessitating les …
Among the screening tests for cervical cancer, advantages of screening with second generation molecular Hybrid Capture 2 (HC2) test i …
Cite